On the recordSeptember 24, 2019
One of the risks of doing the wrong thing in the U.S. on drug pricing can, in my view, severely limit potential access to medication.
Source
congress.govLarry Bucshon: “One of the risks of doing the wrong thing in the U.S. on drug pricing can, in my view, severely limit potential access…”
Editor's note · Context
He warns that poor drug pricing policies could restrict access to necessary medications.
Share
More from Larry Bucshon
Mar 28, 2023
One of my legislative priorities is to increase transparency and accountability in the 340B program.
Sep 23, 2024
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.
Dec 16, 2024
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Valadao). The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend…
May 25, 2023
Again, we need to implement the HALT Fentanyl Act now. Any further delay, including the Biden administration slow- walking its implementation, is unacceptable. I again urge a ``no'' vote on this amendment, and I yield back the balance of…
Other voices in this conversation
